Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Matthew D Galsky; Siamak Daneshmand; Sudeh Izadmehr; Edgar Gonzalez-Kozlova; Kevin G Chan; Sara Lewis; Bassam El Achkar; Tanya B Dorff; Jeremy Paul Cetnar; Brock O Neil; Anishka D’Souza; Ronac Mamtani; Christos Kyriakopoulos; Tomi Jun; Mahalya Gogerly-Moragoda; Rachel Brody; Hui Xie; Kai Nie; Geoffrey Kelly; Amir Horowitz; Yayoi Kinoshita; Ethan Ellis; Yohei Nose; Giorgio Ioannou; Rafael Cabal; Diane M Del Valle; G Kenneth Haines; Li Wang; Kent W Mouw; Robert M Samstein; Reza Mehrazin; Nina Bhardwaj; Menggang Yu; Qianqian Zhao; Seunghee Kim-Schulze; Robert Sebra; Jun Zhu; Sacha Gnjatic; John Sfakianos; Sumanta K Pal

doi:10.1038/s41591-024-02814-0

. 2024 Jan 19;30(4):1211. doi: 10.1038/s41591-024-02814-0

Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Matthew D Galsky ^1,^2,^✉, Siamak Daneshmand ³, Sudeh Izadmehr ¹, Edgar Gonzalez-Kozlova ⁴, Kevin G Chan ⁵, Sara Lewis ⁶, Bassam El Achkar ⁶, Tanya B Dorff ⁷, Jeremy Paul Cetnar ⁸, Brock O Neil ⁹, Anishka D’Souza ¹⁰, Ronac Mamtani ¹¹, Christos Kyriakopoulos ¹², Tomi Jun ^13,²⁵, Mahalya Gogerly-Moragoda ¹, Rachel Brody ^2,¹⁴, Hui Xie ¹⁵, Kai Nie ¹⁵, Geoffrey Kelly ¹⁵, Amir Horowitz ^2,¹⁶, Yayoi Kinoshita ¹⁴, Ethan Ellis ^17,¹⁸, Yohei Nose ¹⁶, Giorgio Ioannou ¹⁶, Rafael Cabal ¹⁶, Diane M Del Valle ¹⁶, G Kenneth Haines ¹⁹, Li Wang ^1,²⁰, Kent W Mouw ²¹, Robert M Samstein ²², Reza Mehrazin ²³, Nina Bhardwaj ^2,^15,¹⁶, Menggang Yu ²⁴, Qianqian Zhao ²⁴, Seunghee Kim-Schulze ^2,^15,¹⁶, Robert Sebra ^2,^17,¹⁸, Jun Zhu ^1,²⁰, Sacha Gnjatic ^2,^15,^16,^#, John Sfakianos ^23,^#, Sumanta K Pal ^7,^#

¹Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY USA

²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA

³Department of Urology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, Los Angeles, CA USA

⁴Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA

⁵Department of Urology, City of Hope Comprehensive Cancer Center, Duarte, CA USA

⁶Department of Radiology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA

⁷Department of Medical Oncology & Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA USA

⁸Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR USA

⁹Department of Urology, University of Utah, Salt Lake City, UT USA

¹⁰Division of Hematology and Medical Oncology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, Los Angeles, CA USA

¹¹Division of Hematology and Medical Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA USA

¹²Division of Hematology and Medical Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI USA

¹³Genentech, South San Francisco, CA USA

¹⁴Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA

¹⁵Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY USA

¹⁶Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA

¹⁷Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY USA

¹⁸Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY USA

¹⁹Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA

²⁰Gene Dx, Stamford, CT USA

²¹Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham & Women’s Hospital, Harvard Medical School, Boston, MA USA

²²Department of Radiation Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA

²³Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA

²⁴Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, WI USA

²⁵Present Address: Formerly with the Icahn School of Medicine at Mount Sinai, New York, NY USA

^✉

Corresponding author.

^#

Contributed equally.

PMCID: PMC11031387 PMID: 38242983

Correction to: Nature Medicine 10.1038/s41591-023-02568-1, published online 2 October 2023.

In the version of the article initially published, Diane M. Del Valle (Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA) was missing from the author list; the surname of Amir Horowitz appeared incorrectly (Horwitz); the ClinicalTrials.gov identifier in the Abstract (now listing NCT03558087) was incorrect; and the Acknowledgements were missing additional thanks. The updates now appear in the HTML and PDF versions of the article.

PERMALINK

Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Matthew D Galsky

Siamak Daneshmand

Sudeh Izadmehr

Edgar Gonzalez-Kozlova

Kevin G Chan

Sara Lewis

Bassam El Achkar

Tanya B Dorff

Jeremy Paul Cetnar

Brock O Neil

Anishka D’Souza

Ronac Mamtani

Christos Kyriakopoulos

Tomi Jun

Mahalya Gogerly-Moragoda

Rachel Brody

Hui Xie

Kai Nie

Geoffrey Kelly

Amir Horowitz

Yayoi Kinoshita

Ethan Ellis

Yohei Nose

Giorgio Ioannou

Rafael Cabal

Diane M Del Valle

G Kenneth Haines

Li Wang

Kent W Mouw

Robert M Samstein

Reza Mehrazin

Nina Bhardwaj

Menggang Yu

Qianqian Zhao

Seunghee Kim-Schulze

Robert Sebra

Jun Zhu

Sacha Gnjatic

John Sfakianos

Sumanta K Pal

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases